This is a record

Captured February 27, 2018 11:30 pm

View Mode: Standard Screenshot
Title
Why Mylan could make more money off a generic version of the EpiPen - Business Insider
Description
The company is now offering a $300 generic version of the EpiPen, which could actually make them more money in the long run.